Press release - 13/10/2025 Miniature 3D-printed objects inside the body Dr. Andrea Toulouse from the Institute of Applied Optics receives €1.8 million in funding from the Carl-Zeiss-Stiftung as part of the CZS Nexus program to establish a new junior research group. She conducts research in the field of micro-optics and fiber-based 3D printing. Her vision is to develop 3D printers that will one day be able to build biological tissue directly inside the body.https://www.gesundheitsindustrie-bw.de/en/article/press-release/miniature-3d-printed-objects-inside-body
Press release - 09/10/2025 Another step towards a cure Vitamin A transporter reactivates latent HIV Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defence and antiviral drugs by becoming "latent". In this state, they are largely invisible and unassailable. As long as these dormant viruses persist, there is no cure for HIV/AIDS. However, researchers at Ulm University Hospital have discovered a new way to reactivate latent HI viruses. https://www.gesundheitsindustrie-bw.de/en/article/press-release/another-step-towards-cure-vitamin-transporter-reactivates-latent-hiv
Press release - 10/10/2025 New tool offers single-cell study of specific genetic variants EMBL scientists created SDR-seq, a tool for single-cell DNA-RNA-sequencing that studies both DNA and RNA simultaneously, linking coding and non-coding genetic variants to gene expression in the same single cell. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tool-offers-single-cell-study-specific-genetic-variants
Press release - 15/10/2025 NGS-based diagnostics for identifying sepsis pathogens wins EARTO Innovation Award A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patients to be identified much faster than before and with the highest precision. The approach is based on high-throughput sequencing of cell-free DNA circulating in the blood and was honored with the EARTO Innovation Award in the "Impact Delivered" category on October 14,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ngs-based-diagnostics-identifying-sepsis-pathogens-wins-earto-innovation-award
Press release - 16/10/2025 ZEW Mannheim To Develop Research on Health Care Markets in the Digital Age The committee of the Joint Science Conference of the federal government and federal states in its meeting cleared the way for the application submitted by ZEW Mannheim for a research programme focusing on the implications of the digital transformation for the analysis and the design of digital health care markets. This paves the way for an expansion of the Institute's activities by establishing an independent health economics research unit. https://www.gesundheitsindustrie-bw.de/en/article/press-release/zew-mannheim-develop-research-health-care-markets-digital-age
Event - 19/11/2025 BW-UK and Beyond: International Networking Evening | MEDICA 2025 Düsseldorf, Networking evening https://www.gesundheitsindustrie-bw.de/en/event/bw-uk-and-beyond-international-networking-evening
Event - 19/11/2025 BW-UK and Beyond: International Networking Evening | MEDICA 2025 Düsseldorf, Networking evening https://www.gesundheitsindustrie-bw.de/en/event/bw-uk-and-beyond-international-networking-evening
Event - 19/11/2025 BW-UK and Beyond: International Networking Evening | MEDICA 2025 Düsseldorf, Networking evening https://www.bio-pro.de/en/events/bw-uk-and-beyond-international-networking-evening
Press release - 16/10/2025 Sleep as the key to understanding ME/CFS The Federal Ministry of Research, Technology and Space (BMFTR) is supporting the “Sleep-Neuro-Path” research network with around 1.6 million euros. Coordinated by the Central Institute of Mental Health (CIMH) in Mannheim, a team of scientists is investigating the role of sleep-related biomarkers in the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleep-key-understanding-mecfs
Help for tracheostomy patients - 23/10/2025 Biomimetic speaking valve: how a carnivorous plant makes speaking safer Nature is the best engineer, so they say, and it's always worth taking a closer look. An interdisciplinary group of researchers did just this and drew inspiration from an aquatic plant to develop a novel speaking valve for tracheostomy patients. At the University Medical Center Freiburg, Dr. Claudius Stahl and his team may have addressed a life-threatening issue that can arise in everyday clinical practice by creating a biomimetic valve with…https://www.gesundheitsindustrie-bw.de/en/article/news/biomimetic-speaking-valve-how-carnivorous-plant-makes-speaking-safer
Press release - 24/10/2025 Freiburg coordinates national early warning system on animal influenza viruses Federal government awards 3.5 million euros in funding to the collaborative research project FLU-PREP. Researchers are developing methods to identify the pandemic potential of new viruses at an early stage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-coordinates-national-early-warning-system-animal-influenza-viruses
Press release - 23/10/2025 Predicting Avian Flu Outbreaks in Europe Using Machine Learning Heidelberg researchers identify local outbreak indicators and develop new regional modeling approach. The highly pathogenic avian influenza virus infection – commonly known as bird flu – primarily affects birds. Mammals, however, are also increasingly infected. This increases the probability that the virus will cross over to humans.https://www.gesundheitsindustrie-bw.de/en/article/press-release/predicting-avian-flu-outbreaks-europe-using-machine-learning
Funding GeneNovate | Call for Application 2025/2026 Funding programme, Funded by: Federal Ministry of Research, Technology and Space, sb_search.searchresult.label.programSubmissionDate: 09/11/2025 https://www.gesundheitsindustrie-bw.de/en/database/funding/genenovate-call-application-20252026
Funding GeneNovate | Call for Application 2025/2026 Funding programme, Funded by: Federal Ministry of Research, Technology and Space, sb_search.searchresult.label.programSubmissionDate: 09/11/2025 https://www.bio-pro.de/en/service/funding/genenovate-call-application-20252026
Press release - 27/10/2025 Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The long-term goal is to develop new preventive strategies against colorectal cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/role-intestinal-bacteria-development-colorectal-cancer-emmy-noether-grant-dkfz-researcher-jens-puschhof
Press release - 28/10/2025 AI solutions from the DKFZ set new standards in medical image processing Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year's world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support and follow-up care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-solutions-dkfz-set-new-standards-medical-image-processing
EU-wide networking of innovation ecosystems for personalised healthcare PRECISEU - PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope https://www.bio-pro.de/en/projects/current-projects/preciseu-personalised-medicine-empowerment-connecting-innovation-ecosystems-across-europe
Press release - 27/10/2025 OnkoAktiv receives Cancer Innovation Award 2025 The nationwide OnkoAktiv network, founded at the National Center for Tumor Diseases (NCT) in Heidelberg, has been awarded the Baden-Württemberg Cancer Innovation Prize 2025. The prize recognizes OnkoAktiv for its pioneering role and groundbreaking contribution to the integration of exercise into oncological care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/onkoaktiv-receives-cancer-innovation-award-2025